BioZorb LP Marker F0221Recalls & reported problems
Focal Therapeutics, Inc. · The Marker is a radiographic implantable marker used to mark soft tissue. It is comprised of a bioabsorbable spacer that holds radiopaque marker clips. · Class 2 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 5
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00851766006061), received between Sep 5, 2023 and Jun 30, 2025 — classified as 5 injuries.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem5
Patient problems
- Breast Discomfort/Pain4
- Breast Mass2
- Deformity/ Disfigurement2
- Hypersensitivity/Allergic reaction2
- Sleep Dysfunction2
- Bacterial Infection1
- Cyst(s)1
- Erythema1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
InjuryJun 30, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A PATIENT RECEIVED A BIOZORB DEVICE IMPLANT ON (B)(6) 2020. FURTHER REPORTED IS THAT THE PATIENT HAS EXPERIENCED INJURIES AT AND AROUND THE SITE OF IMPLANTATION, WHICH INCLUDE PAIN, SLEEP DYSFUNCTION, DEFORMITY, SCARRING, A HARD PAINFUL LUMP, SENSITIVITY, IRRITATION, AND FAILURE TO ABSORB. IT IS REPORTED THAT THE BIOZORB DEVICE WAS REMOVED ON OR AROUND (B)(6) 2024. NO FURTHER INFORMATION IS AVAILABLE AT THIS TIME.
Patient problems: Breast Discomfort/Pain; Breast Mass; Deformity/ Disfigurement; Scar Tissue; Skin Inflammation/ Irritation
MAUDE report 22364941 ↗InjuryNov 22, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A 77-YEAR-OLD PATIENT, RECEIVED A BIOZORB (F0221) ON (B)(6) 2020, DURING A LUMPECTOMY DUE TO AN INFILTRATING LOBULAR CARCINOMA, GRADE2, ER/PR+, HER-2 NEGATIVE AND NODE NEGATIVE. PATIENT RECEIVED ANTIBIOTICS PRE-SURGERY. PATIENT HAD NORMAL POST OP VISITS UNTIL ON (B)(6) 2020 IN WHICH THE PATIENT PRESENTED TO THE PHYSICIAN´S OFFICE WITH A RASH AFFECTING HER ENTIRE RIGHT BREAST IT IS UNKNOWN WHEN IT STARTED. IRRITATION SPREAD THROUGHOUT MOST OF HER BODY AND PATIENT WOULD DESCRIBE IT AS AN ALLERGIC REACTION. PATIENT HAD ALREADY SEEN HER PRIMARY PHYSICIAN AND WAS GIVEN (VISTARIL) ANTIHISTAMINIC BECAUSE SHE WAS NOT TOLERANT OF ORAL STEROIDS. THE TREATMENT WAS NOT CHANGED BUT SHE WAS REFERRED TO AN ALLERGIST. NO ADDITIONAL INFORMATION WAS RECEIVED.
Patient problems: Hypersensitivity/Allergic reaction; Rash
MAUDE report 20758661 ↗InjuryOct 5, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT ON (B)(6) 2021 A BIOZORB PROCEDURE WAS PERFORMED, AND THE PATIENT REPORTED SUFFERS FROM PAIN, SORENESS, SWELLING, AND DISCOMFORT AT AND NEAR THE AREA WHERE THE BIOZORB DEVICE WAS IMPLANTED, WHICH MAKES IT DIFFICULT TO SLEEP. THE PATIENT REPORTED TO DEVELOPED A CYST AROUND THE BIOZORB DEVICE, CAUSING FURTHER PAIN AND SUFFERING. NO ADDITIONAL INFORMATION IS AVAILABLE.
Patient problems: Bacterial Infection; Breast Discomfort/Pain; Cyst(s); Erythema; Swelling/ Edema
MAUDE report 17881491 ↗InjurySep 5, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A PATIENT RECEIVED A BIOZORB IN (B)(6) 2020. THE PATIENT IS REPORTING THAT SHE IS SUFFERING FROM PAIN, ITCHING, REDNESS, TENDERNESS AND DEFORMITY ON HER LEFT BREAST. PATIENT IS ALSO REPORTING THAT SHE HAS HAD TROUBLE SLEEPING . NO OTHER INFORMATION IS AVAILABLE.
Patient problems: Breast Discomfort/Pain; Deformity/ Disfigurement; Hypersensitivity/Allergic reaction; Itching Sensation; Sleep Dysfunction
MAUDE report 17685154 ↗InjurySep 5, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT ON (B)(6) 2018 A BIOZORB WAS IMPLANTED IN THE PATIENT, AND THE PATIENT REPORTED THAT SUFFERS FROM A HARD, PALPABLE LUMP AT THE SITE OF THE BIOZORB, ALSO REPORTED THAT SUFFERS FROM CONSTANT, SEVERE PAIN, TENDERNESS, SENSITIVITY, AND DISCOMFORT IN THE AREA OF THE DEVICE, PAIN WHEN SLEEPING ON HER LEFT SIDE AND SUFFERS FROM PAIN ANY TIME SHE NEEDS TO MOVE HER HAND AND ARM ABOVE HER SHOULDERS, SEVERELY LIMITING HER MOBILITY. NO ADDITIONAL INFORMATION AVAILABLE.
Patient problems: Breast Discomfort/Pain; Breast Mass; Sleep Dysfunction
MAUDE report 17684330 ↗
Other Marker, Radiographic, Implantable devices
- BioZorb F0202Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls192 reports
- BioZorb F0221Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE3 recalls15 reports
- BioZorb F0203Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls51 reports
- BioZorb F0231Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls19 reports
- BioZorb F0303Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls19 reports
- BioZorb F0304Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls19 reports
- BioZorb F0404Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls6 reports
- BioZorb F0331Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls4 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page